-
RBC Capital Downgrades Marinus Pharmaceuticals (MRNS) to Sector Perform
-
UPDATE: RBC Capital Starts Marinus Pharmaceuticals (MRNS) at Outperform
-
Marinus Pharma (MRNS) 5M Common Stock Offering Prices at $6/Share
-
Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Marinus Pharma (MRNS) Poised to Open Lower After Announcing Common Stock Offering
-
Marinus Pharmaceuticals Announces Public Offering of Common Stock